scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1463-1326.2007.00823.X |
P698 | PubMed publication ID | 18034839 |
P2093 | author name string | Lee S | |
Lee KC | |||
Chae SY | |||
Jeon JE | |||
Youn YS | |||
P2860 | cites work | A role for glucagon-like peptide-1 in the central regulation of feeding | Q24314317 |
Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats. | Q33193338 | ||
Nasal drug delivery--possibilities, problems and solutions | Q35078394 | ||
Concept, strategies, and feasibility of noninvasive insulin delivery | Q35615559 | ||
Therapeutic strategies based on glucagon-like peptide 1. | Q35872582 | ||
Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration | Q48094330 | ||
Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1. | Q53864082 | ||
P433 | issue | 4 | |
P304 | page(s) | 343-346 | |
P577 | publication date | 2007-11-22 | |
P1433 | published in | Diabetes, Obesity and Metabolism | Q5270109 |
P1476 | title | PEGylation improves the hypoglycaemic efficacy of intranasally administered glucagon-like peptide-1 in type 2 diabetic db/db mice | |
P478 | volume | 10 |
Q49630159 | Advances in micro- and nanotechnologies for the GLP-1-based therapy and imaging of pancreatic beta-cells |
Q38089879 | Designing PEGylated therapeutic molecules: advantages in ADMET properties |
Q38628696 | Glucagon-Like Peptide-1 Formulation--the Present and Future Development in Diabetes Treatment |
Q42557469 | Glucagon-like peptide-1 functionalized PEG hydrogels promote survival and function of encapsulated pancreatic beta-cells |
Q33858681 | Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers |
Q57369611 | Natural and Synthetic Polymers as Drug Carriers for Delivery of Therapeutic Proteins |
Q27023585 | Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control? |
Q38298423 | Synthesis and Evaluation of a Series of Long-Acting Glucagon-Like Peptide-1 (GLP-1) Pentasaccharide Conjugates for the Treatment of Type 2 Diabetes. |
Q39039567 | Unsaturated glycoceramides as molecular carriers for mucosal drug delivery of GLP-1. |
Search more.